Company Profile

Company Overview

Daiichi Sankyo Pharma Development

On April 1st, 2006, Sankyo Pharma Development and Daiichi Medical Research join together to become Daiichi Sankyo Pharma Development, the U.S. development subsidiary of the two Tokyo-based pharmaceutical companies. The world-wide integration of the two companies will enhance each company’s ability to develop new, breakthrough drugs and continue the history of being bold innovators with strong track records of discovering new classes of medicine. As the two companies share many prioritized domains for research and development, the integration enables the companies to increase both the R&D budget and the number of compounds per domain.

Our researchers are focused on developing breakthrough therapies for the treatment of

• cardiovascular conditions
• metabolic disorders/diabetes
• infection
• cancer
At the heart of Daiichi Sankyo is the fundamental belief that each employee helps shape our success. We’ve created an environment that fosters a balance between collaboration and individual contribution. We provide employees with the training, tools and technology that they need to excel. Through open communication, an emphasis on results and an entrepreneurial spirit, we've created an exceptional working environment where every person's unique skills and abilities are valued and utilized.


Daiichi Sankyo offers a wide range of excellent benefits to it's employees. In addition to an excellent salary program and retirement program, we also offer performance bonus plans and a 401k plan that matches the employee's contributons up to 6% of salary.

Positions Available
This company currently has no jobs posted.

Click here to search for jobs.